BP000045-CYT-331: Recombinant Human Flt3 Ligand
Source: E. coli-derived.
The ED50 range=0.5-1.0 ng/ml corresponding to a specific activity of 1-2 MUnits/mg, calculated by the dose-dependant stimulation of the proliferation of human OCMI-AML5 cells.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000992-PKA-240: Recombinant Human VEGFR1
Source: Insect Cells-derived.
The activity of FLT1 was determined by its ability to abolish the binding of iodinated VEGF to solid surfaces or cell surface receptors. The ED50 for this effect is typically 10 ng/ml, corresponding to a specific activity of 100,000IU/mg.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000992-PKA-354: Recombinant Human VEGFR1, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000988-PKA-234: Recombinant Human VEGFR1 D3
Source: Insect Cells-derived.
The activity of FLT1D1-3 was determined by its ability to abolish the binding of iodinated VEGF to solid surfaces or cell surfaces receptors, and in Far-Western and cross-linking experiments with iodinated VEGF.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000988-PKA-338: Recombinant Human VEGFR1 D3, His Tag
Source: Insect Cells-derived.
Purity > 95%, by RP-HPLC and SDS-PAGE.BP000605-ENZ-412: Recombinant Human FKBP4
Source: E. coli-derived.
Specific activity is > 300 nmoles/min/mg, and is defined as the amount of enzyme that cleaves 1umole of suc-AAFP-pNA per minute at 25C in Tris-Hcl pH 8.0 using chymotrypsin.
Purity > 90%, by SDS-PAGE.BP000601-ENZ-530: Recombinant Human FKBP14
Source: E. coli-derived.
Specific activity is > 240 nmoles/min/mg, and is defined as the amount of enzyme that cleaves 1 umole of suc-AAFP-pNA per minute at 25C in Tris-Hcl pH8.0 using chymotrypsin.
Purity: > 90.0% as determined by SDS-PAGE.BP000489-PRO-448: Human Fibronectin Protein
Source: Human Plasma-derived.
Purity: > 95% by SDS-PAGE.BP000489-PRO-059: Bovine Fibronectin Protein
Source: Bovine Plasma-derived.
Purity: > 95% by SDS-PAGE.BP000489-PRO-131: Rat Fibronectin Protein
Source: Rat Plasma-derived.
Purity: > 95% by SDS-PAGE.